Locations
New York, NY, USA
industry
Biotechnology · DeepTech · Health
Size
11-50 employees
Stage
Other
founded in
2019
Volastra Therapeutics is a clinical-stage biotechnology company based in New York City, focused on developing innovative cancer therapies that target chromosomal instability (CIN). By leveraging proprietary technology and a unique research strategy, Volastra aims to exploit the vulnerabilities of chromosomally unstable cancers through synthetic lethality and immune activation approaches. The company is advancing its pipeline with promising candidates, including a KIF18A inhibitor that has received FDA Fast Track designation. With a commitment to improving patient outcomes, Volastra is positioned to make significant contributions to oncology therapeutics.
Something looks off?On-site & Remote